Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Aug 07, 2014

Mylan Reports Second Quarter 2014 Adjusted Diluted EPS of $0.69, In Line With Guidance

Jul 23, 2014

Mylan Wins Motion for Temporary Restraining Order Against Apotex for Authorized Generic of Paxil® CR

Jul 17, 2014

Mylan Wins Motion to Enjoin GlaxoSmithKline from Providing Paroxetine CR to Apotex; Apotex Can No Longer Supply Authorized Generic Product

Jul 14, 2014

Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction

Jul 08, 2014

Mylan Launches Generic Micardis® Tablets

Jul 01, 2014

Mylan Schedules Second Quarter 2014 Financial Results Conference Call and Live Webcast for Aug. 7, 2014

Jun 11, 2014

Mylan Launches Generic Actonel® Tablets, 150 mg

Jun 09, 2014

Mylan Launches Generic Paraplatin® Injection

Jun 05, 2014

Mylan to Present at the Goldman Sachs 35th Annual Global HealthCare Conference

Jun 02, 2014

/C O R R E C T I O N -- Mylan Specialty L.P./

Pagination

First page
Previous page
…
Page 42
Page 43
Page 44
Page 45
Current page 46
Page 47
Page 48
Page 49
Page 50
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2025 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.